Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0C5XQ
|
|||
Former ID |
DNC006063
|
|||
Drug Name |
5-MEO-DMT
|
|||
Synonyms |
N,N-Dimethyl-5-methoxytryptamine; 5-Methoxy-N,N-dimethyltryptamine; 1019-45-0; Methoxybufotenin; O-Methylbufotenine; Methylbufotenine; MeODMT; 5-MeO-DMT; 5-Methoxydimethyltryptamine; Bufotenine, O-methyl-; 3-(2-Dimethylaminoethyl)-5-methoxyindole; 2-(5-Methoxy-1H-indol-3-yl)-N,N-dimethylethanamine; CT 4334; Methoxydimethyltryptamines; UNII-X0MKX3GWU9; 1H-Indole-3-ethanamine, 5-methoxy-N,N-dimethyl-; NSC 88624; 5-Methoxy-N,N-dimethyl-1H-indole-3-ethanamine; 5-OMe-DMT; INDOLE, 3-(2-(N,N-DIMETHYLAMINO)ETHYL)-5-METHOXY-
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C13H18N2O
|
|||
Canonical SMILES |
CN(C)CCC1=CNC2=C1C=C(C=C2)OC
|
|||
InChI |
1S/C13H18N2O/c1-15(2)7-6-10-9-14-13-5-4-11(16-3)8-12(10)13/h4-5,8-9,14H,6-7H2,1-3H3
|
|||
InChIKey |
ZSTKHSQDNIGFLM-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 1019-45-0
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
10507, 396190, 855873, 3133037, 5496810, 8151306, 10502422, 11111436, 11388126, 11536794, 14773502, 24278119, 26751543, 29221031, 46530517, 47291301, 47440455, 47589168, 47810950, 48035331, 48185166, 48259441, 49747340, 49830131, 49983965, 50100273, 50104133, 57321042, 58004968, 76623346, 81040716, 81093165, 85209445, 92265408, 99381478, 103165737, 104298854, 118048564, 124438278, 124749945, 124801106, 124880659, 124880660, 124880661, 124880662, 124999880, 125336666, 126524284, 126566690, 126572697
|
|||
ChEBI ID |
CHEBI:2086
|
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 145). | |||
REF 2 | 1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity. J Med Chem. 2006 Jan 12;49(1):318-28. | |||
REF 3 | Interaction of N1-unsubstituted and N1-benzenesulfonyltryptamines at h5-HT6 receptors. Bioorg Med Chem Lett. 2006 Nov 15;16(22):5832-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.